Data gathered: December 28
Alternative Data for Stereotaxis
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 5 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 14,000 | Sign up | Sign up | Sign up |
| Employee Rating | 56 | Sign up | Sign up | Sign up |
| Google Trends | 43 | Sign up | Sign up | Sign up |
| Patents | 4 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 18 | Sign up | Sign up | Sign up |
| Facebook Followers | 673 | Sign up | Sign up | Sign up |
| Instagram Followers | 254 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,809 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,232 | Sign up | Sign up | Sign up |
| Twitter Mentions | 17 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 465 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 17 | Sign up | Sign up | Sign up |
| Linkedin Employees | 199 | Sign up | Sign up | Sign up |
About Stereotaxis
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
| Price | $2.29 |
| Target Price | Sign up |
| Volume | 329,440 |
| Market Cap | $209M |
| Year Range | $1.73 - $2.56 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical & Dental Instruments |
In the news
 |
Stereotaxis, Inc. (NYSEAMERICAN:STXS) Shares Purchased by Charles Schwab Investment Management Inc.December 20 - ETF Daily News |
 |
STXS Stock Up Post NMPA Nod for Cardiovascular Care With MagbotDecember 15 - Yahoo |
 |
NMPA approves Stereotaxis and MicroPort’s ablation catheterDecember 9 - Yahoo |
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical SystemsDecember 2 - GlobeNewswire |
|
 |
Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025December 1 - SeekingAlpha |
 |
STXS Stock Up Following the NMPA Clearance of Its Genesis RMN SystemNovember 26 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 9.2M | 5.1M | 4.1M | -6.2M | -6.3M | -0.080 |
| Q2 '24 | 4.5M | 1.2M | 3.3M | -5.8M | -5.9M | -0.070 |
| Q1 '24 | 6.9M | 2.9M | 4M | -4.5M | -4.6M | -0.060 |
| Q4 '23 | 4.6M | 1.8M | 2.7M | -5M | -5.2M | -0.070 |
| Q3 '23 | 7.8M | 3.7M | 4.1M | -5.4M | -5.6M | -0.070 |
Insider Transactions View All
| Isaac Paul J filed to buy 2,768,068 shares at $1.9. August 21 '24 |
| Isaac Paul J filed to buy 2,767,626 shares at $1.9. August 21 '24 |
| Isaac Paul J filed to buy 2,766,814 shares at $1.9. August 20 '24 |
| Isaac Paul J filed to buy 2,765,719 shares at $1.9. June 17 '24 |
| Isaac Paul J filed to buy 2,758,719 shares at $2. June 4 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Align TechnologyALGN |
$211.43 0% | 35 |
 |
DentsplyXRAY |
$18.94 0% | 38 |
 |
LeMaitre VascularLMAT |
$92.84 0% | 39 |
 |
iRhythm TechnologiesIRTC |
$88.8 0% | 23 |
 |
NovoCureNVCR |
$30.7 0% | 37 |
Read more about Stereotaxis (STXS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Stereotaxis?
The Market Cap of Stereotaxis is $209M.
What is the current stock price of Stereotaxis?
Currently, the price of one share of Stereotaxis stock is $2.29.
How can I analyze the STXS stock price chart for investment decisions?
The STXS stock price chart above provides a comprehensive visual representation of Stereotaxis' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Stereotaxis shares. Our platform offers an up-to-date STXS stock price chart, along with technical data analysis and alternative data insights.
Does STXS offer dividends to its shareholders?
As of our latest update, Stereotaxis (STXS) does not offer dividends to its shareholders. Investors interested in Stereotaxis should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Stereotaxis?
Some of the similar stocks of Stereotaxis are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
.